BNP Paribas Discount Zert MHL 29..../ DE000PC2LN72 /
2024-06-03 8:49:42 AM | Chg.+0.59 | Bid10:18:29 AM | Ask10:18:29 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
250.33EUR | +0.24% | 250.75 Bid Size: 100 |
251.55 Ask Size: 100 |
S+P GLOBAL INC. ... | - - | 2025-12-29 | Call |
GlobeNewswire
10:17 AM
Early Signals by WOO X: BTC is in between bulls and bears - watch out for this week’s token unlocks
GlobeNewswire
10:00 AM
Himax to Integrate WiseEye™ with NVIDIA TAO to Advance AI Vision Deployment in a Robust Ecosystem
GlobeNewswire
10:00 AM
Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Di...
GlobeNewswire
10:00 AM
Nokia and Gati Shakti Vishwavidyalaya sign MoU for research collaboration on transportation and logi...
GlobeNewswire
9:55 AM
Ametller Origen Partners with NeoSpectra to Implement Innovative On-Site Food Testing Solutions
GlobeNewswire
9:30 AM
WTW ushers in next generation of climate risk technology with launch of Climate Quantified™
GlobeNewswire
9:00 AM
GBCI report: Denmark and the Netherlands confirm their positions amongst the 10 easiest countries in...
GlobeNewswire
9:00 AM
Nokia selected by Telehouse America to upgrade NYIIX peering exchange infrastructure in the US
GlobeNewswire
8:30 AM
Orion is developing the Finnish life science industry in a unique collaboration project
GlobeNewswire
8:01 AM
Flash News: OKX Announces Adjustments to Minimum Order Quantities for Select Futures Listings
GlobeNewswire
8:00 AM
FTI Consulting Adds Senior Chemicals Industry Expert to Further Expand Business Transformation Pract...
GlobeNewswire
8:00 AM
Caledonia to file preliminary economic assessment on chosen approach to develop the Bilboes sulphide...
GlobeNewswire
8:00 AM
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire
7:48 AM
Flash News: OKX Announces Enhancements to Portfolio Margin Mode to Optimize Trading Experience
GlobeNewswire
7:30 AM
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead C...